An introduction to New Imvaggis (estriol) 0.03mg pessary for Vaginal Atrophy in postmenopausal women, designed with the patient in mind

Presented by
Dr Anne Connolly, GPwSI Gynaecology, Bradford
Dr Sarah Gray, GP specialist in women’s health, Cornwall
Dr. Paula Briggs Consultant, Sexual & Reproductive Health, Southport

To view Prescribing Information

To contact Besins Healthcare

Oestrogen, menopause and VA – Effects, symptoms and QoL
skip to 00:02:41

Treatment Guidelines
skip to 00:15:36

What is Imvaggis?
skip to 00:19:14

Clinical efficacy and pharmokinetics of Imvaggis
skip to 00:22:21

How to use Imvaggis and patient case studies
skip to 00:31:18

Imvaggis summary and Q&A
skip to 00:35:30


8. Grieser et al. (Maturitas, 2012) 14. uk-spc-imvaggis-pessary